title: Imaging of the ovine corpus luteum microcirculation with contrast ultrasound.
abstract: Ultrasound contrast agents have been the subject of microvascular imaging research. The sheep corpus luteum (CL) is a microvascular tissue that provides a natural angiogenic and antiangiogenic process, which changes during the luteal phase of the estrous cycle of the ewe. It can also be controlled and monitored endocrinologically, providing a very attractive in vivo model for the study and development of microvascular measurement. The perfusion of the fully developed CL between days 8 and 12 of the estrous cycle was studied in six ewes. A Philips iU22 ultrasound scanner (Bothell, WA, USA) with the linear array probe L9-3 was used to capture contrast-enhanced images after an intravenous bolus injection of 2.4 mL SonoVue (Bracco S.P.A., Milan, Italy). Time-intensity curves of a region of interest inside the CL were formed from linearized image data. A lagged-normal model to simulate the compartmental kinetics of the microvascular flow was used to fit the data, and the wash-in time was measured. Good contrast enhancement was observed in the CLs of all animals and the wash-in time averaged at 5.5 s with 9% uncertainty. The regression coefficient was highly significant for all fits. These data correlated with stained endothelial area in the histology performed postmortem. Two ewes were injected with prostaglandin F2alpha to induce CL regression, which resulted in an increase of wash-in time after a few hours. The CL of the ewe is thus proposed as an ideal model for the study and development of microvascular measurements using contrast ultrasound. Our initial results demonstrate a highly reproducible model for the study of the microvascular hemodynamics in a range of tissues and organs.
authors.affiliation: Medical Physics and Centre for Cardiovascular Sciences, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK. Vassilis.Sboros@ed.ac.uk
authors.forename: Vassilis
authors.initials: V
authors.lastname: Sboros
authors.forename: M
authors.initials: M
authors.lastname: Averkiou
authors.forename: M
authors.initials: M
authors.lastname: Lampaskis
authors.forename: D H
authors.initials: DH
authors.lastname: Thomas
authors.forename: N
authors.initials: N
authors.lastname: Silva
authors.forename: C
authors.initials: C
authors.lastname: Strouthos
authors.forename: J
authors.initials: J
authors.lastname: Docherty
authors.forename: A S
authors.initials: AS
authors.lastname: McNeilly
mesh_terms: D000818:Animals; D019540:Area Under Curve; D003287:Contrast Media / Q000008:administration & dosage / Q000493:pharmacokinetics*; D003338:Corpus Luteum / Q000000981:diagnostic imaging*; D015237:Dinoprost / Q000494:pharmacology; D030762:Estrous Cycle; D005260:Female; D006439:Hemodynamics; D007091:Image Processing, Computer-Assisted; D008833:Microcirculation; D010743:Phospholipids / Q000008:administration & dosage / Q000493:pharmacokinetics*; D012044:Regression Analysis; D034561:Sheep, Domestic; D013459:Sulfur Hexafluoride / Q000008:administration & dosage / Q000493:pharmacokinetics*; D014463:Ultrasonography
chemical_list: D003287:Contrast Media; D010743:Phospholipids; C420843:contrast agent BR1; D015237:Dinoprost; D013459:Sulfur Hexafluoride